Stockhead on MSN11d
Island Pharmaceuticals starts phase 2b dengue trialProgression to the phase 2b cohort follows recommendation of the Safety Review Committee (SRC) after it reviewed positive ...
Special Report: Australian antiviral drug development company Island Pharmaceuticals has kicked off the phase 2b clinical trial of lead drug ISLA-101 in dengue fever with the first subjects ...
Minister of Health and Social Welfare, Prof Muhammad Ali Pate has reaffirmed the determination of Nigeria and West African sub-region to combat lassa fever with resilience, innovation, and a ...
Stockhead’s Fraser Palamara sits down with Island Pharmaceuticals (ASX:ILA) CEO and managing director David Foster to get the short end of the long story on the company’s latest news.
Below, experts share what COVID-related issues should be instant red flags, plus some advice on what to do: Breathing issues, ...
Island Pharmaceuticals joins Fraser Palamara on Stockhead TV to talk about its Phase 2b trial of ISLA-101 in dengue fever. The Australian antiviral drug development company has kicked off a phase ...
Fueled by raging summer temperatures, persistent droughts and increased construction, valley fever cases spiked in 2024. The ...
A SUSPECTED outbreak of a deadly ‘eye bleeding disease’ has sparked fears of a wider spread. So far, the Ebola-like illness ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback